QyQ, give your head a shake, I haven't turned away from being shareholder friendly. Maybe I am wrong, but I am willing to give credit where credit is due.
The debt ANI retired is long term. They still have their line of credit but they also have accounts receivables, accounts payable and inventory. But they are growing the company look at the net revenue growth. You have to be honest here and look at ANI from where Przybyl took it over in 2009, they had a negative cash flow and bleeding badly to where it is today. The present model is designed to generate higher profits.
ANI has been restructured and is not the same company. I may be wrong, but I believe Pryzbyl has a lot to do with that. He did the same at Akorn and righted the ship got them re-listed and got pps moving North. He appears to have got ANI righted and moving to get them publicly traded albeit through Biosante. So I am willing to give him credit for doing that.
That being said I am not a fan of the bonus agreements. Never said I was. But having read the Akorn's 2003 to 2007 annual reports (Przybyl's letter to shareholders in each report are worth reading) I am a little bullish on Przybyl (not his bonus), especially if he has a similar strategy in place for Biosante.
News 
Market Data 
Discover 
